Beam Therapeutics Inc. · NASDAQ:BEAM

Dapice Joshua J. reported a 9.99% stake in Beam Therapeutics Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 5, 2026

Dapice Joshua J. reported a 9.99% stake in Beam Therapeutics Inc., 10,141,856 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
10,141,856
Intent
Passive
What changed
Stake changed
Filed together
31 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.70%688,623
Farallon Capital Institutional Partners, L.P.0.80%836,691
Farallon Capital Institutional Partners II, L.P.0.20%233,233
Farallon Capital Institutional Partners III, L.P.0.10%104,266
Four Crossings Institutional Partners V, L.P.0.10%150,101
Farallon Capital Offshore Investors II, L.P.1.60%1,632,718
Farallon Capital (AM) Investors, L.P.0.10%94,237
Farallon Capital F5 Master I, L.P.0.30%333,253
Farallon Healthcare Partners Master, L.P.6.00%6,068,735
Farallon Partners, L.L.C.9.70%9,808,603
Farallon Institutional (GP) V, L.L.C.0.10%150,101
Farallon F5 (GP), L.L.C.0.30%333,253
Farallon Healthcare Partners (GP), L.L.C.6.00%6,068,735
Dapice Joshua J.9.99%10,141,856
Dreyfuss, Philip D.9.99%10,141,856
Dunn Hannah E.9.99%10,141,856
Fried, Richard B0%0
Gehani, Varun N.9.99%10,141,856
Giauque, Nicolas9.99%10,141,856
Husen, Avner A.9.99%10,141,856
Kim, David T.9.99%10,141,856
Linn, Michael G.9.99%10,141,856
Luo Patrick (Cheng)9.99%10,141,856
Patel, Rajiv A.0%0
Roberts, Jr., Thomas G.9.99%10,141,856
Saito Edric C.9.99%10,141,856
Seybold, William0%0
Short Daniel S.9.99%10,141,856
Spokes, Andrew J. M.9.99%10,141,856
Warren, John R.9.99%10,141,856
Wehrly, Mark C.9.99%10,141,856

Source

View original at SEC

Related